Nephrotic Syndrome: Albumin, Lipids, and a Leaky Glomerular Filter

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

Blood testing for nephrotic syndrome measures albumin, total protein, LDL, triglycerides, and ApoB to reveal glomerular filter damage—protein loss (Albumin dropping below 3.5 g/dL) drives edema while compensatory lipoprotein overproduction elevates LDL and triglycerides, increasing cardiovascular risk. Trending these markers alongside urine protein-creatinine ratio and eGFR is associated with gauging disease activity and response to kidney-protective therapy.

Read more →

Understand what your kidney function testing results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

Nephrotic syndrome and the markers of a leaky filter

Nephrotic syndrome biomarkers are blood signals that reveal a leaky kidney filter (glomerular filtration barrier) and the body’s downstream responses. The central marker is the main blood protein albumin (serum albumin), made by the liver to hold fluid in blood vessels; low levels reflect loss of this protein into urine. Blood fats rise (lipids: cholesterol and triglycerides) because the liver ramps up production when albumin falls. A waste product from muscle, creatinine (serum creatinine), helps show how well the kidneys are filtering overall. Clotting proteins shift: the natural anticoagulant antithrombin can be lost in urine while fibrinogen is increased by the liver (hemostasis biomarkers), together signaling a higher tendency to form clots. Immune proteins drop, such as protective antibodies (IgG), and transport proteins like vitamin D–binding protein, indicating vulnerability to infection and altered nutrient handling. Cause-finding tests include antibodies against podocyte targets (anti-PLA2R, anti-THSD7A) and complement proteins (C3, C4) that reflect immune-complex activity. Measured together, these biomarkers confirm the syndrome, suggest its cause, indicate severity, and flag complications—enabling focused treatment and safer monitoring.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Why blood markers matter once proteinuria is found

Blood tests in nephrotic syndrome translate kidney filter damage into whole‑body signals. Serum albumin and total protein show how much protein is leaking through the glomerulus, while LDL, triglycerides, and ApoB reveal the liver’s compensatory lipoprotein surge and downstream cardiovascular risk. Together, they map pressure balance in the bloodstream, fluid shifts into tissues, clotting and infection risk, and long‑term effects on the heart and vessels. Common references: albumin about 3.5–5.0 and total protein about 6.0–8.3, with health typically sitting in the mid‑to‑high part of those ranges. LDL and triglycerides are healthiest at the low end (LDL well below 100; triglycerides below 150). ApoB, a count of atherogenic particles, is best toward the low end (often below 80–90). In nephrotic syndrome, albumin and total protein drift low as proteins spill into urine, while LDL, triglycerides, and ApoB climb high as the liver overproduces lipoproteins. High triglycerides can provoke pancreatitis; high ApoB and LDL increase atherosclerotic risk and can coincide with a hypercoagulable state. When albumin and total protein fall, plasma oncotic pressure drops and fluid moves into tissues: puffy eyelids, leg swelling, sudden weight gain, ascites, and shortness of breath from effusions. Fatigue, muscle cramps, and reduced drug and hormone binding may appear; loss of immunoglobulins raises infection susceptibility. Children often show striking facial swelling. In pregnancy, low albumin can amplify edema and hemodynamic strain. Big picture: these biomarkers link renal barrier integrity to vascular health, immunity, and metabolism. Tracking them helps gauge disease activity, cardiovascular and thrombotic risk, and the systemic consequences of sustained protein loss.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

What blood work tells you about a leaky kidney

Nephrotic syndrome blood testing provides a window into the health of your kidneys and their impact on the entire body. The kidneys play a central role in maintaining fluid balance, filtering waste, and regulating proteins and lipids in the blood. When this system is disrupted, it can affect energy levels, cardiovascular health, immunity, and even cognitive function. At Superpower, we test albumin, total protein, LDL, triglycerides, and ApoB to assess these interconnected systems. Albumin is a major blood protein produced by the liver, essential for maintaining fluid balance and transporting hormones, drugs, and nutrients. In nephrotic syndrome, the kidneys lose their ability to retain albumin, leading to low blood levels (hypoalbuminemia). Total protein measures all proteins in the blood, including albumin and globulins; a decrease often signals protein loss through the kidneys. LDL (low-density lipoprotein) and triglycerides are types of blood lipids that often rise in nephrotic syndrome due to altered metabolism and increased liver production. ApoB (Apolipoprotein B) is a structural protein found in LDL and other atherogenic lipoproteins, and its elevation reflects increased cardiovascular risk. Healthy levels of albumin and total protein support stable blood volume, tissue nourishment, and immune defense. When these are low, it signals compromised kidney filtration and systemic instability. Elevated LDL, triglycerides, and ApoB indicate disrupted lipid metabolism, increasing the risk for cardiovascular complications—a common concern in Nephrotic Syndrome. Interpretation of these biomarkers can be influenced by factors such as age, pregnancy, acute illness, certain medications, and laboratory assay differences. These variables should be considered when evaluating results to ensure an accurate understanding of kidney and systemic health.

Frequently Asked Questions

References

  1. Kodner C (2016). Diagnosis and management of nephrotic syndrome in adults. *American Family Physician*, *93*(6), 479-485. https://pubmed.ncbi.nlm.nih.gov/26977832/
  2. Menzel S, Moeller MJ (2011). Role of the podocyte in proteinuria. *Pediatric Nephrology*, *26*(10), 1775-1780. https://doi.org/10.1007/s00467-010-1725-5
  3. Singhal R, Brimble KS (2006). Thromboembolic complications in the nephrotic syndrome: Pathophysiology and clinical management. *Thrombosis Research*, *118*(3), 397-407. https://doi.org/10.1016/j.thromres.2005.03.030
  4. Attman PO, Alaupovic P (1990). Pathogenesis of hyperlipidemia in the nephrotic syndrome. *American Journal of Nephrology*, *10*(Suppl 1), 69-75. https://doi.org/10.1159/000168197
  5. National Institute of Diabetes and Digestive and Kidney Diseases. (2022). *Nephrotic syndrome in adults*. https://www.niddk.nih.gov/health-information/kidney-disease/nephrotic-syndrome-adults

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey